Kintegral Advisory LLC Sells 2,211 Shares of HCA Healthcare, Inc. (NYSE:HCA)

by · The Cerbat Gem

Kintegral Advisory LLC lessened its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 32.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,511 shares of the company’s stock after selling 2,211 shares during the period. Kintegral Advisory LLC’s holdings in HCA Healthcare were worth $1,559,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. Atwood & Palmer Inc. bought a new position in shares of HCA Healthcare during the 1st quarter worth approximately $28,000. Bartlett & CO. Wealth Management LLC increased its holdings in shares of HCA Healthcare by 888.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company’s stock valued at $31,000 after purchasing an additional 80 shares during the last quarter. ORG Partners LLC lifted its stake in shares of HCA Healthcare by 344.0% during the 1st quarter. ORG Partners LLC now owns 111 shares of the company’s stock worth $38,000 after buying an additional 86 shares during the last quarter. Tidemark LLC bought a new position in HCA Healthcare in the 4th quarter valued at about $36,000. Finally, Legacy Investment Solutions LLC boosted its holdings in shares of HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company’s stock worth $62,000 after acquiring an additional 95 shares during the period. 62.73% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on HCA shares. Robert W. Baird reissued a “neutral” rating and set a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Morgan Stanley set a $410.00 target price on shares of HCA Healthcare and gave the company an “equal weight” rating in a research report on Monday, June 9th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $404.00 price target (up from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Wells Fargo & Company upgraded shares of HCA Healthcare from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $320.00 to $385.00 in a research report on Thursday, May 29th. Finally, Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Friday, June 27th. Eight investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $395.71.

Get Our Latest Stock Report on HCA

HCA Healthcare Stock Down 1.4%

Shares of NYSE:HCA opened at $372.84 on Friday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a market capitalization of $89.69 billion, a PE ratio of 16.58, a price-to-earnings-growth ratio of 1.31 and a beta of 1.47. The company has a fifty day moving average of $370.64 and a 200-day moving average of $338.65.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts’ consensus estimates of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The firm had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. During the same period in the previous year, the firm posted $5.36 EPS. The company’s revenue for the quarter was up 5.7% compared to the same quarter last year. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were given a $0.72 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.77%. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.81%.

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).